.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
AstraZeneca
Farmers Insurance
US Army
Moodys
Daiichi Sankyo
McKesson
Teva
QuintilesIMS
Cipla

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203182

« Back to Dashboard
NDA 203182 describes CISATRACURIUM BESYLATE PRESERVATIVE FREE, which is a drug marketed by Sandoz Inc, Jiangsu Hengrui Med, and Fresenius Kabi Usa, and is included in three NDAs. It is available from three suppliers. Additional details are available on the CISATRACURIUM BESYLATE PRESERVATIVE FREE profile page.

The generic ingredient in CISATRACURIUM BESYLATE PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.

Summary for NDA: 203182

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Pharmacology for NDA: 203182

Suppliers and Packaging for NDA: 203182

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CISATRACURIUM BESYLATE PRESERVATIVE FREE
cisatracurium besylate
INJECTABLE;INJECTION 203182 ANDA Fresenius Kabi USA, LLC 63323-416 63323-416-05 10 VIAL in 1 CARTON (63323-416-05) > 5 mL in 1 VIAL
CISATRACURIUM BESYLATE PRESERVATIVE FREE
cisatracurium besylate
INJECTABLE;INJECTION 203182 ANDA Fresenius Kabi USA, LLC 63323-418 63323-418-20 10 VIAL in 1 CARTON (63323-418-20) > 20 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2MG BASE/ML
Approval Date:Feb 26, 2015TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10MG BASE/ML
Approval Date:Feb 26, 2015TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Cerilliant
Argus Health
Julphar
Cantor Fitzgerald
Medtronic
Chinese Patent Office
Mallinckrodt
Accenture
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot